Table 3 Top 20 re-uses with highest Altmetric Attention Scores
Published outputs | Title | Theme | Platform | Type of study | Altmetric score | Tweets | Policy sources | Newspapers |
|---|---|---|---|---|---|---|---|---|
Joanna Le Noury et al. 2015 | Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence | Psychology/psychiatry (child and adults) | CSDR | Re-analysis | 1407.5 | X | X | X |
F Hieronymus et al. 2017 | Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression | Psychology/psychiatry (child and adults) | CSDR | Meta-analysis | 262.6 | X | Â | X |
Johannes Schneider-Thoma et al. 2018 | Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials | Psychology/psychiatry (child and adults) | YODA | Meta-analysis | 132.7 | X | Â | X |
Johannes Schneider-Thoma et al. 2019 | Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis | Psychology/psychiatry (child and adults) | YODA | Meta-analysis | 107.9 | X | Â | X |
Monique B. Nilsson et al. 2017 | Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with ß-blockers | Medicine (adults) | CSDR | Secondary analysis | 101.6 | X |  | X |
John M. Dennis et al. 2018 | Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data | Medicine (adults) | CSDR | Secondary analysis | 91.8 | X | Â | X |
Sarah J Nevitt et al. 2017 | Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review | Medicine (adults) | CSDR | Methodological | 64.9 | X | Â | Â |
Siddharth Singh et al. 2018 | No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials | Medicine (adults) | YODA | Meta-analysis | 60.7 | X | Â | X |
Akbar K. Waljee et al. 2019 | Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn Disease | Medicine (adults) | YODA | Secondary analysis | 59.4 | X | Â | X |
Z.Z.N. Yiu et al. 2019 | A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis | Medicine (adults) | YODA | Methodological | 55.6 | X | Â | X |
Hawkins C. Gay et al. 2017 | Feasibility, Process, and Outcomes of Cardiovascular Clinical Trial Data Sharing | Medicine (adults) | YODA | Re-analysis | 46 | X | Â | X |
Merryn Voysey et al. 2017 | The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses | Paediatric | CSDR | Meta-analysis | 37.3 | X | X | X |
Ymkje Anna de Vries et al. 2018 | Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis | Psychology/psychiatry (child and adults) | CSDR | Meta-analysis | 30.4 | X | Â | Â |
Shereen Oon et al. 2019 | Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus | Medicine (adults) | CSDR | Secondary analysis | 29.9 | X | Â | X |
Ymkje Anna Vries et al. 2018 | Initial severity and antidepressant efficacy for anxiety disorders, obsessive–compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis | Psychology/psychiatry (child and adults) | CSDR | Meta-analysis | 29.8 | X |  |  |
Joseline Guetsop Zafack et al. 2019 | Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials | Medicine (adults) | CSDR | Secondary analysis | 29.6 | X | X | Â |
Andriy Noshchenko et al. 2015 | What Is the Clinical Relevance of Radiographic Nonunion After Single-Level Lumbar Interbody Arthrodesis in Degenerative Disc Disease? | Medicine (adults) | YODA | Meta-analysis | 27.9 | X | Â | X |
Runsheng Wang et al. 2018 | Comparative Efficacy of Tumor Necrosis Factor-a Inhibitors in Ankylosing Spondylitis: A Systematic Review and Bayesian Network Metaanalysis | Medicine (adults) | YODA | Meta-analysis | 26.6 | X | Â | X |
Jacob Spertus et al. 2018 | Risk of weight gain for specific antipsychotic drugs: a meta-analysis | Psychology/psychiatry (child and adults) | YODA | Meta-analysis | 25.6 | X | Â | X |
Amber L. Laurie et al. 2016 | Meta-analysis of the Impact of Patient Characteristics on Estimates of Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Lumbar Spinal Fusion | Medicine (adults) | YODA | Meta-analysis | 23.5 | X | Â | X |